tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALKS Stock Latest News

Alkermes Partners with Amneal for VIVITROL® Distribution
Company AnnouncementsAlkermes Partners with Amneal for VIVITROL® Distribution
6d ago
8K
ALKS
Alkermes Appoints Joshua Reed as New CFO
PremiumCompany Announcements
Alkermes Appoints Joshua Reed as New CFO
6d ago
8K
ALKS
Alkermes names Joshua Reed as CFO
PremiumThe Fly
Alkermes names Joshua Reed as CFO
6d ago
ALKS
RBC lists biotech winners should RFK depart HHS
PremiumThe Fly
RBC lists biotech winners should RFK depart HHS
8d ago
ALKS
AXSM
RBC lists biotech winners should RFK departure HHS
PremiumThe Fly
RBC lists biotech winners should RFK departure HHS
8d ago
ALKS
AXSM
Alkermes price target lowered to $43 from $45 at Needham
PremiumThe FlyAlkermes price target lowered to $43 from $45 at Needham
9d ago
TAK
ALKS
Alkermes price target raised to $35 from $34 at JPMorgan
Premium
The Fly
Alkermes price target raised to $35 from $34 at JPMorgan
9d ago
TAK
ALKS
Questions remain after Alkermes narcolepsy data, says H.C. Wainwright
Premium
The Fly
Questions remain after Alkermes narcolepsy data, says H.C. Wainwright
9d ago
ALKS
Alkermes Hold Rating: Promising NT1 Data Amidst Competitive and Clinical Challenges
PremiumRatings
Alkermes Hold Rating: Promising NT1 Data Amidst Competitive and Clinical Challenges
9d ago
ALKS
Cautious Hold Rating on Alkermes Amid Competitive Pressures and Mixed Data for ALKS2680
PremiumRatings
Cautious Hold Rating on Alkermes Amid Competitive Pressures and Mixed Data for ALKS2680
9d ago
ALKS
Jefferies says stage set for Centessa to differentiate in narcolepsy
PremiumThe Fly
Jefferies says stage set for Centessa to differentiate in narcolepsy
10d ago
TAK
ALKS
Alkermes narcolepsy data ‘solid,’ about as expected, says Leerink
PremiumThe Fly
Alkermes narcolepsy data ‘solid,’ about as expected, says Leerink
10d ago
ALKS
Promising Clinical Results and Market Potential Drive Buy Rating for Alkermes
PremiumRatingsPromising Clinical Results and Market Potential Drive Buy Rating for Alkermes
10d ago
ALKS
Alkermes narcolepsy type 1 data largely as expected, says Mizuho
Premium
The Fly
Alkermes narcolepsy type 1 data largely as expected, says Mizuho
10d ago
ALKS
Alkermes Announces Positive Phase 2 Study Results
Premium
Company Announcements
Alkermes Announces Positive Phase 2 Study Results
10d ago
8K
ALKS
Alkermes announces Vibrance-1 study meets primary endpoint
PremiumThe Fly
Alkermes announces Vibrance-1 study meets primary endpoint
10d ago
ALKS
Alkermes initiated with an Overweight at Wells Fargo
PremiumThe Fly
Alkermes initiated with an Overweight at Wells Fargo
16d ago
TAK
ALKS
Alkermes Hold Rating: Balancing Strong Performance with Alixorexton Uncertainties
PremiumRatings
Alkermes Hold Rating: Balancing Strong Performance with Alixorexton Uncertainties
2M ago
ALKS
Alkermes’ Hold Rating: Balancing Strong Revenue Growth with Orexin Program Uncertainties
PremiumRatings
Alkermes’ Hold Rating: Balancing Strong Revenue Growth with Orexin Program Uncertainties
2M ago
ALKS
Alkermes Reports Strong Q2 2025 Financial Results
PremiumCompany AnnouncementsAlkermes Reports Strong Q2 2025 Financial Results
2M ago
ALKS
Alkermes Earnings Call: Strong Growth and Promising Trials
Premium
Company Announcements
Alkermes Earnings Call: Strong Growth and Promising Trials
2M ago
ALKS
Alkermes price target lowered to $33 from $35 at BofA
Premium
The Fly
Alkermes price target lowered to $33 from $35 at BofA
2M ago
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >